Table 2.
Comparison of interstitial lung disease groups.
| IPF (n=16) | Sarcoidosis (n=21) | Mixed group (n=42) | P value | |
|---|---|---|---|---|
| Age, years | 62.0±9.4 | 48.7±8.4 | 56.1±11.7 | <0.001 |
| Female, number % | 5 (31.3%) | 12 (57.1%) | 21 (50.0%) | 0.277 |
| BMI kg/m2 | 27.9±4.8 | 30.2±4.4 | 28.1±4.6 | 0.215 |
| Warrick score | 23.5 (19–27.7) | 9 (6.5–12) | 11 (6–19.5) | <0.001 |
| FEV1 mL% | 78 (62–91.5) | 81 (70–102.5) | 83.5 (69–103.2) | 0.293 |
| FVC mL% | 71 (62–85.25) | 78 (66–98) | 85.5 (73.2–103.1) | 0.061 |
| FEV1/FVC% | 107 (100–114) | 102 (94–105) | 103 (95.5–113) | 0.268 |
| DLCO mL/Hg/min | 59.5 (47–78.7) | 72 (47.5–82) | 71 (55–81) | 0.393 |
| OSA(+) | 12 (75%) | 13 (61%) | 28 (66%) | 0.700 |
IPF – idiopathic pulmonary fibrosis; BMI – body mass index; FEV1 – forced expiratory volume at 1 second; FVC – forced vital capacity; DLCO – carbon monoxide diffusion test; OSA – obstructive sleep apnea.